Table 1. Clinical samples used in this study.
| Samplea | Week-Year Sampled | Island of Origin | RNA copies/ml | Accession Number |
|---|---|---|---|---|
| M100 | 52–2013 | MART | 6.2E+07 | LN898093 |
| G100 | 2–2014 | GUA | 1.7E+04 | LN898094 |
| M101 | 3–2014 | MART | 4.7E+04 | LN898095 |
| M102 | 3–2014 | MART | 2.5E+07 | LN898096 |
| G101 | 3–2014 | GUA | 1.6E+07 | LN898097 |
| G102 | 3–2014 | GUA | 2.5E+06 | LN898098 |
| G103 | 3–2014 | GUA | 3.5E+06 | LN898099 |
| M103 | 3–2014 | MART | 2.1E+07 | LN898100 |
| M104 | 3–2014 | MART | 2.8E+07 | LN898101 |
| G104 | 3–2014 | GUA | 2.2E+07 | LN898102 |
| G105 | 3–2014 | GUA | 3.0E+06 | LN898103 |
| M105 | 3–2014 | MART | 9.4E+06 | LN898104 |
| M106 | 3–2014 | MART | 3.3E+06 | LN898105 |
| M107 | 3–2014 | MART | 1.3E+07 | LN898106 |
| M108 | 3–2014 | MART | 8.6E+05 | LN898107 |
| M109 | 4–2014 | MART | 4.8E+07 | LN898108 |
| M110 | 4–2014 | MART | 4.5E+06 | LN898109 |
| G106 | 5–2014 | GUA | 8.7E+07 | LN898110 |
| G107 | 5–2014 | GUA | 3.6E+06 | LN898111 |
| M111 | 3–2014 | MART | 8.0E+06 | LN898112 |
| M112 | 3–2014 | MART | 2.1E+06 | n/a |
| M113 | 4–2014 | MART | 7.6E+04 | n/a |
| M114 | 4–2014 | MART | 2.8E+04 | n/a |
| M115 | 3–2014 | MART | 1.5E+06 | n/a |
| M116 | 3–2014 | MART | 1.2E+03 | n/a |
aIndividual in which infectious clone was derived.
MART = Martinique, GUA = Guadeloupe, n/a—not submitted to bank, incomplete genome coverage